A randomized, controlled trial to assess the safety of switching stable renal transplant patients from Sandimmun to Sandimmun Neoral.
Loo
C S
CS
Department of Nephrology, Hospital Kuala Lumpur, Malaysia.
Morad
Z
Z
Lim
T O
TO
Fan
K S
KS
Suleiman
A B
AB
D000284:Administration, Oral; D000328:Adult; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004304:Dosage Forms; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D018579:Patient Selection; D011795:Surveys and Questionnaires
D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine